Moderna seeks US and EU authorisation for Covid-19 vaccine

Moderna Inc has applied for US and European emergency authorization for its COVID-19 vaccine after full results from a late-stage study showed it was 94.1% effective with no serious safety concerns, the company said. Video: Reuters

Associated article


LATEST STORIES